Open AccessAbstract CT159: First-in-human dose escalation of AlphaMedixTMfor targeted alpha-emitter therapy of neuroendocrine tumors
Author(s) -
Izabela Tworowska,
Ebrahim S. Delpassand,
Julien Torgue,
Farah Shanoon,
Jason Hurt,
Rodolfo Núñez
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct159
Subject(s) - medicine , radionuclide therapy , neuroendocrine tumors , dosing , somatostatin , somatostatin receptor , target lesion , gastroenterology , oncology , nuclear medicine , percutaneous coronary intervention , myocardial infarction